skip to Main Content
Blue Shield California February 2018 Medical Policy Updates

Blue Shield California February 2018 Medical Policy Updates

Click here to view the Blue Shield California Medical Policy Updates »

February 2018 Medical Policy Updates:

  • Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry
  • Amniotic Membrane and Amniotic Fluid
  • Artificial Pancreas Device Systems
  • Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions
  • Balloon Ostial Dilation for Treatment of Chronic Rhinosinusitis
  • Beta-Amyloid Imaging with Positron Emission Tomography for Alzheimer Disease
  • Bioengineered Skin and Soft Tissue Substitutes
  • Bone Turnover Markers for the Diagnosis and Management of Osteoporosis and Diseases Associated With High Bone Turnover
  • Brachytherapy for Clinically Localized Prostate Cancer Using Permanently Implanted Seeds
  • Cardiovascular Risk Panels
  • Cerebrospinal Fluid and Urinary Biomarkers of Alzheimer Disease
  • Charged-Particle (Proton or Helium Ion) Radiotherapy for Neoplastic Conditions
  • Chemical Peels
  • Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid
  • Coronary Computed Tomography Angiography with Selective Noninvasive Fractional Flow Reserve
  • Cytochrome p450 Genotyping
  • Dermatologic Applications of Photodynamic Therapy
  • Digital Breast Tomosynthesis
  • Drug Testing in Pain Management and Substance Abuse Treatment
  • Elective Revascularization Utilizing Percutaneous Coronary Intervention for Non-Acute, Stable Coronary Artery Disease
  • Endobronchial Brachytherapy
  • Fecal Analysis in the Diagnosis of Intestinal Dysbiosis
  • General Approach to Evaluating the Utility of Genetic Panels
  • General Approach to Genetic Testing
  • Genetic Cancer Susceptibility Panels Using Next-Generation Sequencing
  • Genetic Testing for Alpha Thalassemia
  • Genetic Testing for Dilated Cardiomyopathy
  • Genetic Testing for Fanconi Anemia
  • Genetic Testing for Predisposition to Inherited Hypertrophic Cardiomyopathy
  • Hematopoietic Cell Transplantation for Primary Amyloidosis
  • Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disease
  • Hysterectomy Surgery for Benign Conditions
  • Identification of Microorganisms Using Nucleic Acid Probes
  • Immune Cell Function Assay
  • Injectable Clostridial Collagenase for Fibroproliferative Disorders
  • Interferential Current Stimulation
  • Intraoperative Neurophysiologic Monitoring
  • Intraoperative Radiotherapy
  • Laboratory and Genetic Testing for Use of 5-Fluorouracil in Patients with Cancer
  • Laboratory Testing for HIV Tropism
  • Laser Treatment of Onychomycosis
  • Light Therapy for Psoriasis
  • Light Therapy for Vitiligo
  • Lipid Apheresis
  • Lumbar Spine Surgery
  • Measurement of Lipoprotein-Associated Phospholipase A2 in the Assessment of Cardiovascular Risk
  • Moderate Penetrance Variants Associated with Breast Cancer in Individuals at High Breast Cancer Risk
  • Multimarker Serum Testing Related to Ovarian Cancer
  • Nerve Fiber Density Measurement
  • Nonpharmacologic Treatment of Rosacea
  • Nutrient/Nutritional Panel Testing
  • Pharmacogenomic and Metabolite Markers for Patients Treated with Thiopurines
  • Quantitative Assay for Measurement of HER2 Total Protein Expression and HER2 Dimers
  • Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors
  • Serum Biomarker Human Epididymis Protein 4
  • Synthetic Cartilage Implants for Joint Pain
  • Temporomandibular Joint Dysfunction
  • Testing Serum Vitamin D Levels
  • Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease
  • Treatment of Varicose Veins/Venous Insufficiency

 

Click here to view the Blue Shield California Medical Policy Updates »

 

Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!

Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top